Differential Modulation of μ- and δ-Opioid Receptor Agonists by Endogenous RGS4 Protein in SH-SY5Y Cells
Authors:
- Lee-Yuan Liu-ChenLLLee-Yuan Liu-Chen
- John R. TraynorJTJohn R. Traynor
Open Access
- 1 July 2009
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (27) , 18357-18367
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- N-Glycan-mediated Quality Control in the Endoplasmic Reticulum Is Required for the Expression of Correctly Folded δ-Opioid Receptors at the Cell SurfaceJournal of Biological Chemistry, 2008
- Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cellsBrain Research, 2007
- Regulator of G protein signaling proteins differentially modulate signaling of μ and δ opioid receptorsEuropean Journal of Pharmacology, 2007
- N-Terminal Residues Control Proteasomal Degradation of RGS2, RGS4, and RGS5 in Human Embryonic Kidney 293 CellsMolecular Pharmacology, 2007
- Cellular mechanisms that determine selective RGS protein regulation of G protein-coupled receptor signalingSeminars in Cell & Developmental Biology, 2006
- Endogenous RGS Protein Action Modulates μ-Opioid Signaling through GαoJournal of Biological Chemistry, 2003
- Receptor-selective Effects of Endogenous RGS3 and RGS5 to Regulate Mitogen-activated Protein Kinase Activation in Rat Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2002
- Regulators of G-Protein signalling as new central nervous system drug targetsNature Reviews Drug Discovery, 2002
- Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH‐SY5Y cellsBritish Journal of Pharmacology, 2002
- Potential Role for a Regulator of G Protein Signaling (RGS3) in Gonadotropin-Releasing Hormone (GnRH) Stimulated DesensitizationEndocrinology, 1997